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ABSTRACT - The central nervous system and the immune system are closely related. Psy- 
chiatric illness is often associated with a dysregulation of the immune response. In an attempt 
to expand on previously reported immune abnormalities in patients with depressive illness, 
we compared several immune measures in a group of hospitalized depressed patients and 
healthy normal controls. Depressed patients had significantly higher percentages of circulat- 
ing neutrophils, significantly lower percentages of circulating lymphocytes and significantly 
lower in vitro lymphocyte responses to mitogenic stimulation than normal controls. Basal 
plasma cortisol and circulating levels of the complement components C3 and C4 were also 
higher in the depressed group. We also found a significant association between cortisol 
values and the traffic of leukocytes on the one hand, and complement levels and the lympho- 
cyte mitogenic activities on the other. These findings expand previously reported evidence of 
immune abnormalities in depressive illness and provide a partial explanation for some of 
these findings. 
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There is now ample evidence of interactions 
between the central nervous system and the immune 
system (1). Both stress (2,3) and psychiatric illness 
(4,5) have been associated with impairment in 
immune function. We have earlier reported a reduc- 
tion in mitogen-induced lymphocyte proliferation 
in patients with depressive illness (6). Our findings 
have been replicated by several investigators (7,8). 
Most of the studies so far have examined only 1 or 2 
aspects of immune function at a time in a small num- 
ber of patients. In this study, we compared several 
aspects of immune function (leukocyte traffic, lym- 
phocyte subsets, mitogen responses and immuno- 
globulin levels) in a relatively large population of 
hospitalized depressed patients and normal controls. 
Because cortisol has often been suspected of playing 
a major role as a link between the central nervous 
system and the immune system (9), we also exam- 
ined the relationship between plasma cortisol values 
and the different immune function tests. Serum 
complement is also an important mediator of 
immune function and is often increased in certain 
types of psychological stress as an “acute phase reac- 
tant” (10). We therefore compared circulating levels 
of 2 complement components C3 and C4 in 
depressed patients and normal controls and exam- 
ined the relationship between these proteins and dif- 
ferent immune variables. 
Material and methods 
Subjects 
Subjects for the study were recruited from consecu- 
tive admissions to the University of Iowa Psychiatric 
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hospital. Patients were included in the study if they 
met DSM-III(11) criteria for major depressive dis- 
order, were free of major medical or neurological 
disorders known to interfere with immune regulation 
such as infection or cancer, free of alcoholism and 
drug abuse, and free of medication known to affect 
immune function. Psychoactive drugs as such were 
not, however, considered exclusion criteria. Forty 
patients, 18 male, 22 female, were included in the 
study. The mean (+SD) age of the depressed 
patients was 42.6 f16.4 years. Their age range was 
21-76 years. They scored a mean (fSD) of 26.2 
+9.8 on the Carroll Rating Scale for Depression. 
Blood for immune and endocrine investigation was 
collected as soon as possible following the patient’s 
admission to the hospital, usually within 10 days fol- 
lowing admission. Normal controls were healthy vol- 
unteers who were free of medical and psychiatric ill- 
ness and were not taking medication at the time of 
the study. The mean (+SD) age of the control group 
was 31.3 k9.0 years (range 20-58). Nineteen sub- 
jects were male; 18 were female. They scored a mean 
(kSD) of 1.7 51.5 on the Carroll Rating Scale for 
Depression. Both patients and controls who partici- 
pated in the study had all given informed consent. 
Methods 
Blood collection. Twenty milliliters of blood were 
drawn from each subject between 8:OO a.m. and 
9:00 a.m. in a heparinized tube. Whenever possible, 
blood samples from patients and controls were 
drawn and processed together on the same day to 
control for day-to-day variation in the assay. A total 
white blood cell (WBC) count and differential was 
performed on each sample using standard proce- 
dures. The blood was then centrifuged over Ficoll- 
Hypaque and the lymphocytes separated for culture 
or surface marker analyses (see below). The plasma 
was frozen and stored at -70°C for cortisol, immuno- 
globulin and complement level analysis (see below) 
Lymphocyte mitogenic stimulation. Lymphocyte 
cultures were established in triplicate as previously 
described (6). To each well, one of the following 
mitogens was added: no mitogen for background 
transformation (blank); phytohemagglutinin-P 
(PHA), 2.5 pg/ml; concanavalin A (Con A), 10 
pg/ml; and pokeweed mitogen (PWM), 2.5 pg/ml. 
These concentrations were chosen because they 
were associated with maximum stimulation in our 
laboratory. The cultures were kept for 4 days prior to 
addition of tritiated thymidine and harvesting. Tri- 
tiated thymidine uptake was then measured with a 
scintillation counter. Mean scintillation counts per 
minute (cpm) were calculated for each mitogen, and 
the 2 groups were compared. 
Surface marker analysis. For the surface marker 
analyses, lymphocytes from each subject were 
washed several times and incubated separately with 
one of the following commercially available mono- 
clonal antibodies (Coulter Immunology, Hialeah, 
FL, USA): CD20 for total B lymphocytes; CD2 for 
total T lymphocytes; CD4 for T helper/inducer 
cells; and CD8 for T suppressor/cytoxic cells. The 
cells were then washed again and incubated with a 
fluorescein-conjugated second antibody (GAM- 
FITC, Coulter Immunology). The frequency (per- 
centage) of each cell type was then determined with 
fluorescent microscopy. 
Immunoglobulin, complement and cortisol levels. 
Immunoglobulin and complement levels of plasma 
samples were measured using a standard radial 
immunodiffusion kit (Nor-Partigen, Calbiochem- 
Behring, La Jolla, CA, USA). Plasma cortisol was 
measured using a standard radioimmunoassay 
procedure. 
Statistical analysis. Because the difference in age 
distribution between depressed patients and normal 
controls was statistically significant (P<O.OOl), 
comparisons on all other dependent variables 
between the 2 groups were done using analysis of 
covariance (ANCOVA), with age as a covariate. A 
difference between the 2 groups was considered stat- 
istically significant when P<0.05. For correlations 
between the endocrine and immune variables, we 
calculated Pearson’s correlation coefficient (r) .  All 
levels of significance were two-tailed. 
Results 
Results of the hematological variables in depressed 
patients and normal controls are shown in Table 1. 
There were no significant differences in hematocrit 
between depressed patients and normal controls. 
WBC counts, however, were significantly higher in 
the depressed groups (P<O.Ol).  The percentage of 
neutrophils was also significantly higher among 
depressed patients (P<O.OOl). The percentages of 
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Table 1 
Hematological variables 
Depression Normal controls 
~~ 
Hematocrit (%) 45.1k4.1 43.8k3.5 
WBC count (per mm3) 8565k3016 6787k 1799** 
Neutrophil (%) 64.1k 11.5 53.1*10.0*** 
Lymphocyte (%) 29.5k 10.7 38.5k9.7** 
Monocyte (%) 3.6k1.9 5.0k2.2' 
Eosinophils (%) 2.1f1.7 2.6k1.3 
Basophils (%) 0.82k0.81 0.73k0.84 
Means f SD; *P<0.05; **P<O.Ol; ***P<O.OOl 
Table 2 
Lymphocyte subset populations' 
Depression Normal controls 
Total lymphocytes' 2490k1071 25401629 
B cells 231k103 241f 154 
T cells 1574+811 17091553 
T helperiinducer cells 9371499 998f322 
T suppressor/cytotoxic cells 5865362 647k238 
T helpers/T suppressors 1.7910.84 1.63f0.48 
*Results are expressed as number of cells per mm3; means f SD. 
lymphocytes and monocytes, on the other hand, 
were significantly lower in the depressed group 
(P(O.01 and P(0.05, respectively). No significant 
differences in the percentages of eosinophils or baso- 
phils emerged between the 2 groups. 
Table 2 summarizes the results of the different 
lymphocyte subsets between the depressed patients 
and the normal controls. There were no significant 
differences in either the absolute numbers of lym- 
phocytes or the percentage of the different lympho- 
cyte subsets between the 2 groups. Similarly, the 
ratio of helper-to-suppressor T lymphocytes (CD4/ 
CD8) was not significantly different between 
depressed patients and normal controls. 
Results of the in vitm lymphocyte response to 
mitogen stimulation are shown in Table 3. There 
were no significant differences in the unstimulated 
lymphocyte responses (blank). Lymphocytic 
responses to the mitogens PHA, Con A and PWM 
were lower in the depressed patients compared with 
normal controls. These differences were statistical- 
ly significant for Con A (P<O.OOl) and PWM 
(P<O.OS) but not for PHA. 
Results of immunoglobulin, complement and cor- 
tisol values are shown in Table 4. Immunoglobulin M 
was slightly higher among depressed patients 
(P<0.05) than among normal controls. The immu- 
noglobulins IgG and IgA were not significantly dif- 
ferent among the groups. The complement compo- 
nents C3 and C4 were higher among the depressed 
patients than among the normal controls (P(O.01 
and P<0.05, respectively). Cortisol values were also 
higher among the depressed group (P< 0.001). 
Table 5 summarizes correlations between plasma 
cortisol values and selected immune measures. 
There was a positive correlation between plasma 
Table 3 
Lymphocyte mitogenic responses 
Depression Normal controls 
~ 
Blank 1,056f859 940+702 
PHA (2.5 pg/ml) 146,253+60,546 177,773*66,867 
(218.5k175.8) (244.51122.4) 
Con A (10 pgiml) 88,815*47,037 151,067*84,373*** 
(121.8* 106.4) (185.2k 100.0) 
PWM (2.5 pg/ml) 77,716*28,820 109,275?62,559* 
(110.9185.8) (137.8f68.7) 
Results are expressed as scintillation cpm: means k SD. The ratio 
of stimulated to unstimulated lymphocytes for each of the mitogens 
is shown in parentheses. *P<0.05, ***P<O.001. 
Table 4 
Immunoglobulins, complement components and plasma cortisol 
levels 
Depression Normal controls 
IgG (g/l) 12.34k3.11 12.32f3.22 
IgM ( d l )  1.70k0.75 1.66f0.76*a 
c3 ( g 4  0.87+0.15 0.76f0.10** 
c 4  ( d l )  0.4150.14 0.36f0.87* 
Cortisol (wg/l) 161k42 108i52*** 
IgA ( d l )  2.0f0.79 1.88fO.83 
~~ 
Means f SD. *P<O.OS; **P<O.Ol; ***P<0.001. "Thedifference 
in IgM values, although small, is statistically significant because of a 
strong negative correlation between IgM values and age. Statistical 
analyses were done with ANCOVA with age as a covariate. 
Table 5 
Correlations between basal cortisol values and selected immune 
measures 
Immune measure r 
WBC count 0.10 
Neutrophil (%) 0.37** 
Lymphocyte (%) -0.35** 
PHA -0.04 
Con A -0.04 
PWM -0.07 
**P<0.01 
LYMPHOCYTE AND lg DEPRESSION 145 
Table 6 
Correlations between complement components C, and selected 
immune measures 














cortisol values and the percentage of neutrophils 
(P<O.Ol), and a negative correlation between 
plasma cortisol values and the percentage of lym- 
phocytes (P< 0.0 1). There were no significant 
correlations between plasma cortisol values and 
lymphocyte subsets, lymphocyte mitogenic respon- 
ses, immunoglobulin or complement levels. 
Relations between complement component C4 
and selected immune variables are shown in Table 6. 
There was a positive correlation between C4 and 
WBC counts ( ~ 0 . 2 5 ,  P(0.05). There were also 
negative correlations between C4 and the lympho- 
cytic responses to all 3 mitogens, PHA 
( r =  -0.37;P<0.01), Con A ( r=  -0.33;P<0.01) 
and PWM (r=-0.26;P<0.05). These was also a 
strong positive correlation between C3 and C4 
( r  = 0.47;P< 0.001). 
Discussion 
This study was undertaken to further explore 
possible abnormalities in immune functioning in 
depressed patients compared with normal controls. 
The results indicate significant differences in the 
number and traffic of leukocytes, a significant reduc- 
tion in lymphocyte responsiveness to mitogenic 
stimulation, and a significant increase in plasma 
levels of IgM, complement components C3 and C4 
and cortisol values in the depressive group. Results 
regarding the traffic of leukocytes that consist of an 
increase in the percentage of neutrophils and a 
decrease in the percentage of lymphocytes and 
monocytes confirm our previously reported findings 
in an unmedicated group of depressive patients (12). 
Further, there were no significant differences in the 
traffic of leukocytes between unmedicated 
depressed patients ( ~ 1 0 )  and those who were 
receiving psychotropic medications (n=30). These 
findings, as we speculated earlier, are consistent with 
the expected hematological effects of higher cortisol 
values in the depressed group: an increase in the per- 
centage of neutrophils and a decrease in the percent- 
age of lymphocytes. The significant correlations 
between plasma cortisol values and neutrophil and 
lymphocyte percentages (Table 5) provide further 
confirmation of a probable relationship between 
plasma cortisol values and the traffic of leukocytes. 
The distribution of lymphocyte subsets, on the 
other hand, did not differ significantly between 
depressed patients and normal controls. These 
results are consistent with previous reports in the lit- 
erature (13), although some data, like our own, did 
show a tendency for CD4/CD8 to be higher among 
depressed patients (14). It should, however, be 
noted that we investigated, with the use of monoclo- 
nal antibodies, only 4 different markers on the sur- 
face of the lymphocytes. Technology is expanding 
rapidly in this field and there are presently more than 
20 different markers on the surface of the lympho- 
cyte that can be quantified and compared. A more 
comprehensive evaluation of lymphocyte surface 
markers identifymg newer lymphocyte subsets and 
using flow cytometry technology is presently under- 
way. 
Results concerning the lymphocyte responses to 
mitogenic stimulation confirm our previous findings 
(6), which have since been replicated by several 
investigators (7,8). It should, however, be noted that 
unlike our previous report, which described lympho- 
cyte mitogenic responses in depressed patients who 
were drug-free for at least 2 weeks, the present data 
were obtained on depressed patients, the majority of 
whom were receiving psychotropic medications. 
Still, because of the possibility that psychotropic 
medications may affect lymphocyte mitogenic activ- 
ity, we compared lymphocytic responses in the 
unmedicated depressed patients (n= 10) with those 
who were receiving psychotropic medications 
( ~ 3 0 ) .  There were no significant differences in the 
responses to any of the mitogens used. These results 
further confirm the reduction in lymphocyte 
mitogenic activity among depressed patients and 
suggest that psychotropic medications alone cannot 
explain the differences observed between patients 
and controls. 
Results of the plasma .concentrations of the 
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immunoglobulins IgG, IgM and IgA showed a mild 
increase in the depressed group. This increase was 
statistically significant for IgM, but not for IgG or 
IgA. Again, these results are consistent with most 
published reports (15,16). The findings of signifi- 
cant increases in the complement components C3 
and C4 were somewhat unexpected. Only one group 
of investigators have reported an elevation of C4, 
but not C3, in patients with bipolar psychosis (15). 
Our results confirm and expand these findings. An 
increase in C3 and C4, together with elevations in 
WBC counts and the levels of circulating immuno- 
globulins, suggest an acute phase reaction such as the 
result of viral or antigenic stimulation. The signifi- 
cant increase in plasma cortisol values in depressed 
patients is consistent with previous reports of hyper- 
cortisolemia in depressive illness (17), and may also 
accompany the acute phase reaction. Again, there 
were no significant differences between medicated 
and unmedicated depressed patients in immunoglo- 
bulin, complement or cortisol values. 
Because an increase in complement components 
has been associated with a reduction of the immune 
response (18), we examined the relationship 
between plasma C4 values and the different immune 
variables (Table 6). We found a significant positive 
correlation between C4 and WBC counts and signi- 
ficant negative correlations between C4 and each of 
the 3 mitogens used. These results are suggestive of 
an association between the elevated complement 
components and the reduction in lymphocyte 
mitogenesis. 
In summary, we compared a group of hospitalized 
depressed patients and a group of healthy, normal 
controls on several immunological tests. Depressed 
patients had higher neutrophil percentages and 
lower lymphocyte percentages than normal controls. 
These findings may be explained on the basis of 
higher cortisol values among the depressed group. 
Depressed patients also had lower lymphocyte 
mitogenic responses than the control group. These 
findings cannot be explained by the higher cortisol 
values, but may possibly be related to the higher 
complement levels in the depressed group. Further 
research on the interaction between hormones and 
immunity in depression is warranted. 
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